Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › NEJM Evidence

NEJM Evidence

Q1 Journal Scopus Active Journal
Country
United States
Northern America
Subject Area and Category
Medicine
└ Drug Discovery Q1
└ Medicine (miscellaneous) Q1
└ Pharmacology Q1
SJR 2025
3.979
Q1
SJR Score
H-Index
19
Citations / Doc (2yr)
6.20
Total Docs. (latest)
81
Total Citations (3yr)
921
Publication type
Journals
ISSN
27665526
Coverage
2022-2025
Journal Rank
#439
Advertisement

Subject Categories

Drug Discovery Q1
Medicine (miscellaneous) Q1
Pharmacology Q1

Aims & Scope

The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to clinical practice, have not followed suit. NEJM Evidence expands the corpus of published research with a focus on providing more context and critical evaluation of the methods and results to support clinical decision-making and does so in a way that respects the time and commitment of the practitioner. NEJM Evidence seeks to advance clinical trial research and clinical practice by: • Publishing high-quality studies from the front lines of medical research. • Challenging the medical community to take new approaches to clinical trial design and execution that yield more powerful clinical evidence. • Sparking debate and conversation around areas of medicine where clinical decisions are made without sufficient evidence. • Engaging physicians in a more sophisticated and meaningful way with clinical evidence.

Abstracting & Indexing

Scopus Google Scholar Medline

Detailed Metrics

Total Docs. (latest) 81
Total Docs. (3 years) 149
Total Refs. 1,719
Total Citations (3 years) 921
Citable Docs. (3 years) 91
Citations / Doc. (2 years) 6.20
Ref. / Doc. 21.22
% Female 41.1%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of NEJM Evidence?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, NEJM Evidence has an SJR of 3.979 and is ranked Q1.

What is the SJR and quartile of NEJM Evidence?

NEJM Evidence has an SJR (SCImago Journal Rank) of 3.979 and its best quartile is Q1.

What is the H-index of NEJM Evidence?

The H-index of NEJM Evidence is 19, meaning 19 of its articles have each been cited at least 19 times.

Is NEJM Evidence indexed in Scopus?

Yes. NEJM Evidence is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR3.979
Best QuartileQ1
H Index19
ISSN27665526
PublisherMassachussetts Medical Society
CountryUnited States
RegionNorthern America
Coverage2022-2025
Open AccessNo
TypeJournal
Rank#439

Similar Journals

View all Medicine journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=3804" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★